The Hip Fracture Surgery in Elderly Patients (HIPELD) study: protocol for a randomized, multicenter controlled trial evaluating the effect of xenon on postoperative delirium in older patients undergoing hip fracture surgery

Trials

Volumn 13, Issue , 2012, Pages

  Coburn, Mark ^a   Sanders, Robert D ^b   Maze, Mervyn ^c   Rossaint, Rolf ^a   Belda, J ^d   Borghi, B ^e   Rosencher, N ^f   Arnold, G ^g   Albaladejo, P ^h   Capdevila, X ⁱ   Minville, V ^j   Kienbaum, P ^k   Kunitz, O ^l   Mynard, V ^m   Chong, C F ^m  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^f Groupe Hospitalier Cochin Saint Vincent de Paul ^*  (France)

^g IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^h HÔPITAL MICHALLON   (France)

ⁱ LAPEYRONIE HOSPITAL   (France)

^j CHU RANGUEIL   (France)

^k UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^l Emergency and Intensive Care Medicine   (Germany)

^m AIR LIQUIDE   (France)

more..

Author keywords

Hip fracture; Postoperative delirium; Xenon

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; SEVOFLURANE; XENON;

AGED; ANESTHESIA INDUCTION; ARTICLE; CONTROLLED STUDY; GENERAL ANESTHESIA; HIP FRACTURE; HIP SURGERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTOPERATIVE DELIRIUM; RANDOMIZED CONTROLLED TRIAL;

AGE FACTORS; AGED; ANESTHETICS, INHALATION; COST-BENEFIT ANALYSIS; DELIRIUM; DRUG COSTS; EUROPE; FRACTURE FIXATION, INTERNAL; HIP FRACTURES; HOSPITAL COSTS; HUMANS; METHYL ETHERS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME; XENON;

EID: 84866635893     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-180     Document Type: Article

References (33)

1. Sanders RD, Pandharipande PP, Davidson AJ, Ma D, Maze M. Anticipating and managing postoperative delirium and cognitive decline in adults. BMJ 2011, 343:d4331. 10.1136/bmj.d4331, 21775401.
2. Inouye SK. Delirium in older persons. N Engl J Med 2006, 354:1157-1165. 10.1056/NEJMra052321, 16540616.
3. Furlaneto ME, Garcez-Leme LE. Delirium in the elderly individuals with hip fracture: causes, incidence, prevalence, and risk factors. Clinics (Sao Paulo) 2006, 61:35-40.
4. Fong TG, Jones RN, Shi P, Marcantonio ER, Yap L, Rudolph JL, Yang FM, Kiely DK, Inouye SK. Delirium accelerates cognitive decline in Alzheimer disease. Neurology 2009, 72:1570-1575. 10.1212/WNL.0b013e3181a4129a, 2677515, 19414723.
5. Fong TG, Tulebaev SR, Inouye SK. Delirium in the elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol 2009, 5:210-220. 10.1038/nrneurol.2009.24, 3065676, 19347026.
6. Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK. One-year health care costs associated with delirium in the elderly population. Arch Intern Med 2008, 168:27-32. 10.1001/archinternmed.2007.4, 18195192.
7. Sanders RD. Hypothesis for the pathophysiology of delirium: role of baseline brain network connectivity and changes in inhibitory tone. Med Hypotheses 2011, 77:140-143. 10.1016/j.mehy.2011.03.048, 21498007.
8. Sanders RD, Franks NP, Maze M. Xenon: no stranger to anaesthesia. Br J Anaesth 2003, 91:709-717. 10.1093/bja/aeg232, 14570795.
9. Derwall M, Coburn M, Rex S, Hein M, Rossaint R, Fries M. Xenon: recent developments and future perspectives. Minerva Anestesiol 2009, 75:37-45.
10. Faulkner S, Bainbridge A, Kato T, Chandrasekaran M, Kapetanakis AB, Hristova M, Liu M, Evans S, De Vita E, Kelen D, Sanders RD, Edwards AD, Maze M, Cady EB, Raivich G, Robertson NJ. Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia. Ann Neurol 2011, 70:133-150. 10.1002/ana.22387, 21674582.
11. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005, 58:182-193. 10.1002/ana.20547, 16049939.
12. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, Akimov S, Sanders RD, Franks NP, Maze M. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006, 26:199-208. 10.1038/sj.jcbfm.9600184, 16034370.
13. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006, 105:187-197. 10.1097/00000542-200607000-00029, 16810011.
14. Coburn M, Maze M, Franks NP. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 2008, 36:588-595. 10.1097/01.CCM.0B013E3181611F8A6, 18216607.
15. Coburn M, Kunitz O, Baumert JH, Hecker K, Haaf S, Zühlsdorff A, Beeker T, Rossaint R. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth 2005, 94:198-202. 10.1093/bja/aei023, 15531620.
16. Rossaint R, Reyle-Hahn M, Schulteam Esch J, Scholz J, Scherpereel P, Vallet B, Giunta F, Del Turco M, Erdmann W, Tenbrinck R, Hammerle AF, Nagele P, . Xenon Study Group Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003, 98:6-13. 10.1097/00000542-200301000-00005, 12502972, Xenon Study Group.
17. Fries M, Nolte KW, Coburn M, Rex S, Timper A, Kottmann K, Siepmann K, Häusler M, Weis J, Rossaint R. Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med 2008, 36:2420-2426. 10.1097/CCM.0b013e3181802874, 18664790.
18. Ma D, Lim T, Xu J, Tang H, Wan Y, Zhao H, Hossain M, Maxwell PH, Maze M. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 2009, 20:713-720. 10.1681/ASN.2008070712, 2663824, 19144758.
19. Rajakumaraswamy N, Ma D, Hossain M, Sanders RD, Franks NP, Maze M. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models. Neurosci Lett 2006, 409:128-133. 10.1016/j.neulet.2006.09.020, 17052852.
20. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confussion assessment method. A new method for detection of delirium. Ann Intern Med 1990, 113:941-948.
21. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on " sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793-1800. 10.1097/00003246-199811000-00016, 9824069.
22. Pandharipande PP, Shintani AK, Hagermann HE, St Jacques PJ, Rice TW, Sanders NW, Ware LB, Bernard GR, Ely EW. Derivation and validation of SpO2/FiO2 ratio in the respiratory component of the Seqential Organ Failure Assessment score. Crit Care Med 2009, 37:1317-1321. 10.1097/CCM.0b013e31819cefa9, 19242333.
23. Aldrete JA. The post-anesthesia recovery score revisted. J Clin Anesth 1995, 7:89-91. 10.1016/0952-8180(94)00001-K, 7772368.
24. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for prediciting postoperative nausea and vomiting: conclusion from cross-validations between two centers. Anesthesiology 1999, 91:693-700. 10.1097/00000542-199909000-00022, 10485781.
25. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P, van Gool WA. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005, 53:1658-1666. 10.1111/j.1532-5415.2005.53503.x, 16181163.
26. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001, 49:516-522. 10.1046/j.1532-5415.2001.49108.x, 11380742.
27. Marcantonio E, Ta T, Duthie E, Resnick NM. Delirium severity and psychomotor types: their relationship with outcomes after hip fracture repair. J Am Geriatr Soc 2002, 50:850-857. 10.1046/j.1532-5415.2002.50210.x, 12028171.
28. Marcantonio ER, Flacker JM, Michaels M, Resnick NM. Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc 2000, 48:618-624.
29. Zakriya KJ, Christmas C, Wenz JF, Franckowiak S, Anderson R, Sieber FE. Preoperative factors associated with postoperative change in confusion assessment method score in hip fracture patients. Anesth Analg 2002, 94:1628-1632.
30. Zakriya K, Sieber FE, Christmas C, Wenz JF, Franckowiak S. Brief postoperative delirium in hip fracture patients affects functional outcome at three months. Anesth Analg 2004, 98:1798-1802.
31. Sharma PT, Sieber FE, Zakriya KJ, Pauldine RW, Gerold KB, Hang J, Smith TH. Recovery room delirium predicts postoperative delirium after hip-fracture repair. Anesth Analg 2005, 10:1215-1220.
32. Galanakis P, Bickel H, Gradinger R, Von Gumppenberg S, Forstl H. Acute confusional state in the elderly following hip surgery: incidence, risk factors and complications. Int J Geriatr Psychiatry 2001, 16:349-355. 10.1002/gps.327, 11333420.
33. Wei LA, Fearing MA, Sternberg EJ, Inouye SK. The Confussion Assessment Method: a systematic review of current usage. J Am Geriatric Soc 2008, 56:823-830.